We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KEEL
1601
PUT
Keel Infrastructure Corp
KEEL
$2.04B
| $3.07M | ﹤0.01% |
+1,305,000
| New | +$4.47M |
|
1602
CALL
SoundHound AI
SOUN
$3.32B
| $3.06M | ﹤0.01% |
+307,400
| New | +$4.42M |
|
1603
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $3.03M | ﹤0.01% |
71,049
-566,551
| -89% | -$25.1M |
|
1604
PUT
Toll Brothers
TOL
$14B
| $3.03M | ﹤0.01% |
+22,400
| New | +$3.04M |
|
|
PPTA
1605
Perpetua Resources
PPTA
$3.1B
| $3.03M | ﹤0.01% |
125,092
-122,212
| -49% | -$3.01M |
|
1606
PUT
AT&T
T
$168B
| $3.02M | ﹤0.01% |
121,700
+77,400
| +175% | +$1.96M |
|
1607
Avis
CAR
$4.84B
| $3.02M | ﹤0.01% |
+23,549
| New | +$3.29M |
|
1608
Constellation Brands
STZ
$23.3B
| $3.02M | ﹤0.01% |
21,857
+9,492
| +77% | +$1.3M |
|
1609
Aaon
AAON
$7.23B
| $3.01M | ﹤0.01% |
39,538
-69,320
| -64% | -$6.4M |
|
|
APLS
1610
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $3.01M | ﹤0.01% |
+120,000
| New | +$2.82M |
|
1611
Gilead Sciences
GILD
$171B
| $3.01M | ﹤0.01% |
24,527
+18,723
| +323% | +$2.28M |
|
1612
Rocket Lab Corp
RKLB
$51.2B
| $3M | ﹤0.01% |
42,984
+20,491
| +91% | +$1.17M |
|
1613
DT Midstream
DTM
$13.8B
| $2.99M | ﹤0.01% |
+24,998
| New | +$2.87M |
|
1614
PUT
KeyCorp
KEY
$24.6B
| $2.99M | ﹤0.01% |
+144,800
| New | +$2.7M |
|
1615
PUT
Blue Owl Capital
OWL
$19.7B
| $2.99M | ﹤0.01% |
+200,000
| New | +$3.13M |
|
1616
ePlus
PLUS
$2.31B
| $2.98M | ﹤0.01% |
33,925
+9,170
| +37% | +$757K |
|
1617
ClearPoint Neuro
CLPT
$470M
| $2.97M | ﹤0.01% |
+217,274
| New | +$4.03M |
|
1618
AutoZone
AZO
$49.6B
| $2.96M | ﹤0.01% |
872
-770
| -47% | -$2.91M |
|
|
SVM
1619
Silvercorp Metals
SVM
$2.61B
| $2.95M | ﹤0.01% |
+353,243
| New | +$2.57M |
|
1620
CALL
Snap
SNAP
$8.96B
| $2.95M | ﹤0.01% |
365,600
+194,100
| +113% | +$1.54M |
|
1621
CALL
Vale
VALE
$58.7B
| $2.95M | ﹤0.01% |
226,000
-12,500
| -5% | -$152K |
|
1622
Arthur J. Gallagher & Co
AJG
$65B
| $2.94M | ﹤0.01% |
11,370
-617,139
| -98% | -$163M |
|
1623
PUT
Edwards Lifesciences
EW
$53.4B
| $2.94M | ﹤0.01% |
34,500
-17,700
| -34% | -$1.45M |
|
1624
Caleres
CAL
$461M
| $2.94M | ﹤0.01% |
+241,629
| New | +$2.97M |
|
1625
Donnelley Financial Solutions
DFIN
$1.22B
| $2.94M | ﹤0.01% |
+62,934
| New | +$3.04M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.